Mutagenic impact and evolutionary influence of radiotherapy in hematologic malignancies.
Saved in:
| Title: | Mutagenic impact and evolutionary influence of radiotherapy in hematologic malignancies. |
|---|---|
| Authors: | Diamond B; Myeloma Institute, Sylvester Comprehensive Cancer Center, University of Miami, Miami, FL, USA., Chahar D; Lymphoma Service, Sylvester Comprehensive Cancer Center, Miami, FL, USA., Jain MD; Lymphoma Service, Moffitt Cancer Center, Tampa, FL, USA., Poos AM; Heidelberg Myeloma Center, Department of Internal Medicine V, Heidelberg University Hospital, Medical Faculty, Heidelberg University, Heidelberg, Germany.; Clinical Cooperation Unit Molecular Hematology/Oncology, Department of Internal Medicine V, Heidelberg University Hospital, Heidelberg University, and German Cancer Research Center (DKFZ), Heidelberg, Germany., Durante M; Myeloma Institute, Sylvester Comprehensive Cancer Center, University of Miami, Miami, FL, USA., Ziccheddu B; Myeloma Institute, Sylvester Comprehensive Cancer Center, University of Miami, Miami, FL, USA., Kaddoura M; Myeloma Institute, Sylvester Comprehensive Cancer Center, University of Miami, Miami, FL, USA., Papadimitriou M; Myeloma Institute, Sylvester Comprehensive Cancer Center, University of Miami, Miami, FL, USA., Maclachlan K; Myeloma Service, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Jelinek T; Department of Hemato-Oncology, University Hospital Ostrava and Faculty of Medicine, University of Ostrava, Czech Republic., Davies F; Myeloma Research Program, NYU Langone, Perlmutter Cancer Center, New York, NY, USA., Figura NB; Department of Radiation Oncology, Moffitt Cancer Center, Tampa, FL, USA., Morgan G; Myeloma Research Program, NYU Langone, Perlmutter Cancer Center, New York, NY, USA., Mai E; Heidelberg Myeloma Center, Department of Internal Medicine V, Heidelberg University Hospital, Medical Faculty, Heidelberg University, Heidelberg, Germany., Weisel KC; Department of Oncology, Hematology and Blood and Marrow Transplant, University Medical Center Hamburg-Eppendorf, Hamburg, Germany., Fenk R; Department of Hematology, Oncology and Clinical Immunology, University-Hospital Duesseldorf, Duesseldorf, Germany., Raab MS; Heidelberg Myeloma Center, Department of Internal Medicine V, Heidelberg University Hospital, Medical Faculty, Heidelberg University, Heidelberg, Germany.; Clinical Cooperation Unit Molecular Hematology/Oncology, Department of Internal Medicine V, Heidelberg University Hospital, Heidelberg University, and German Cancer Research Center (DKFZ), Heidelberg, Germany., Usmani S; Myeloma Service, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Landgren O; Myeloma Institute, Sylvester Comprehensive Cancer Center, University of Miami, Miami, FL, USA., Locke FL; Lymphoma Service, Moffitt Cancer Center, Tampa, FL, USA., Goldschmidt H; Heidelberg Myeloma Center, Department of Internal Medicine V, Heidelberg University Hospital, Medical Faculty, Heidelberg University, Heidelberg, Germany., Schatz JH; Lymphoma Service, Sylvester Comprehensive Cancer Center, Miami, FL, USA., Weinhold N; Heidelberg Myeloma Center, Department of Internal Medicine V, Heidelberg University Hospital, Medical Faculty, Heidelberg University, Heidelberg, Germany.; Clinical Cooperation Unit Molecular Hematology/Oncology, Department of Internal Medicine V, Heidelberg University Hospital, Heidelberg University, and German Cancer Research Center (DKFZ), Heidelberg, Germany., Maura F; Myeloma Institute, Sylvester Comprehensive Cancer Center, University of Miami, Miami, FL, USA. |
| Source: | BioRxiv : the preprint server for biology [bioRxiv] 2024 Nov 18. Date of Electronic Publication: 2024 Nov 18. |
| Publication Type: | Journal Article; Preprint |
| Journal Info: | Country of Publication: United States NLM ID: 101680187 Publication Model: Electronic Cited Medium: Internet ISSN: 2692-8205 (Electronic) Linking ISSN: 26928205 NLM ISO Abbreviation: bioRxiv Subsets: PubMed not MEDLINE |
| Database: | MEDLINE Ultimate |
Be the first to leave a comment!
